CrossAssetDataThe Company File
···
GRDN

Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. is classed by the SEC under Retail-Drug Stores and Proprietary Stores (industry code 5912), based in Atlanta, GA. Its filings are on EDGAR under CIK 1802255; the figures the desk reads are not on file yet.

Retail business Retail-Drug Stores and Proprietary Stores Atlanta, GA filings since 2020 4 of 9 filed, 5 estimated
Ask the desk about GRDN → Compare GRDN with BBW → Price chart on TradingView ↗ Full EDGAR file ↗ Watch GRDN →

Sector peers: BBWBNEDSPWHBGI

6.5/10headline grade
vs its business-model standard
5.5/10past 7.9/10present 5.3/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a retail business: prior from its industry code (SEC 5912, Retail-Drug Stores and Proprietary Stores); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 6.5 out of ten, 4 of 9 metrics filed and 5 estimated: past 5.5 out of ten, present 7.9 out of ten, future 5.3 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 7.5 out of ten. No warning events in its filings since 2020. 75th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 5.1 out of ten. CrossAssetData estimate 5.1/10, confidence 20 of 100 (family median). 50th percentile among 16 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
  • Shareholder treatment (past): 1.9 out of ten. CrossAssetData estimate 1.9/10, confidence 35 of 100 (one part). 19th percentile among 18 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Financial health (present): 7.8 out of ten. ROE 23%: 23¢ of profit per shareholder dollar. Leverage 47%: owes 47¢ per asset dollar. 78th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 7.6 out of ten. top 24% of 18 in its family; net margin 3.4%. 76th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 8.8 out of ten. CrossAssetData estimate 8.8/10, confidence 35 of 100 (one part). 88th percentile among 13 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Room to expand (future): 5.5 out of ten. top 45% of 18 in its family for room to expand. 55th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 5.2 out of ten. CrossAssetData estimate 5.2/10, confidence 20 of 100 (family median). 50th percentile among 16 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
  • Expectations vs reality (future): 5.3 out of ten. CrossAssetData estimate 5.3/10, confidence 20 of 100 (family median). 50th percentile among 16 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.

The filing record

Newest annual report: Form 10-K filed 2026-03-11 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-06 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-06 (on EDGAR). Newest filing: Form 4, 2026-09-28. Filings on record since 2020. Read from EDGAR 2026-10-12.

Who runs it

Burke, Fred (President and Chief Executive Officer); Crisafulli, Chris (Senior Vice President, Payor and Industry Strategy); Eakins, Richard (Senior Vice President, Sales); Forbes, Kendall (Executive Vice President, Sales & Operations); Martin, David Norman (Senior Vice President, Technology, Data & Senior Security Officer); Morris, David K (Executive Vice President, Chief Operating Officer); Mudd, William Franklin (Senior Vice President, Chief Financial Officer); Towns, Douglas (Senior Vice President, General Counsel, Senior Compliance Officer & Corporate Secretary); Tuch, Jeffrey (Senior Vice President, Purchasing & Pricing Analytics); Weir, Robert (Senior Vice President, Operations & Regulatory Support); and 6 more. 16 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.